Jean-François Dehecq
Profile
Mr. Jean-François Dehecq is Chairman at Groupe Maori SAS, Chairman at Pierre Balmain SA, Chairman-Orientation Committee at Bpifrance Participations SA /PRIVATE EQUITY/, Independent Director at Air France-KLM SA, a Member at Fondation Française pour la Recherche sur l'Epilepsie, and Chairman at Sanofi Espoir Corporate Foundation.
He is on the Board of Directors at Provepharm SAS, Balmain SA, Air France-KLM SA, L'Agence Nationale de la Recherche, and Conference Nationale de l'Industrie.
Mr. Dehecq was previously employed as Independent Director by Veolia Environnement SA, Chairman by Sanofi-Aventis SA, Chairman by Association Nationale de la Recherche et de la Technologie, Chairman by Ecole Nationale Supérieure d’Arts et Métiers, and Vice Chairman by European Federation of Pharmaceutical Industries & Assns.
He also served on the board at International Federation of Pharmaceutical Manufacturers A.
He received his undergraduate degree from Ecole Nationale Supérieure d’Arts et Métiers.
Jean-François Dehecq active positions
| Companies | Position | Start |
|---|---|---|
Bpifrance Participations SA /PRIVATE EQUITY/
Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance BPIfrance Participations PE is an active, medium-term manager which aims to support small,medium and intermediate-sized French companies with growth potential, particularly in technology-related sectors. They also invest in large companies with liquidity issues and may exceptionally consider investing directly in seed and start-up companies. The firm targets companies with strong products and significant long-term sales potential which are facing short-term balance sheet difficulties. Their key investment criteria include viability and profitability. They get actively involved in strategic decisions, encourage the R&D activity within their investee companies, and promote social and environmental responsibility. BPIfrance Participations PE invests primarily in the form of direct equity, possibly complemented with near equity, convertible debt and warrants. They typically take minority stakes and favor co-investing with public or private sector partners, including foreign investors. They consider investments across sectors within the real economy, such as technology, industrials and services. They avoid financials, real estate, retail and non-competitive activities. The firm's exit horizon and strategy are flexible and take into account the time requirements of the R&D process as well as the state of the economy. | Corporate Officer/Principal | 09/12/2009 |
L'Agence Nationale de la Recherche
L'Agence Nationale de la Recherche General GovernmentGovernment Promotes and funds scientific research efforts, public and private. | Director/Board Member | 09/12/2009 |
Fondation Française pour la Recherche sur l'Epilepsie | Corporate Officer/Principal | 11/04/2010 |
Sanofi Espoir Corporate Foundation | Chairman | 18/07/2011 |
Conference Nationale de l'Industrie | Director/Board Member | - |
Groupe Maori SAS | Chairman | 26/12/2011 |
Former positions of Jean-François Dehecq
| Companies | Position | End |
|---|---|---|
| AIR FRANCE-KLM | Director/Board Member | 18/05/2016 |
| VEOLIA ENVIRONNEMENT | Director/Board Member | 14/03/2012 |
Arts Et Metiers Paristech
Arts Et Metiers Paristech Other Consumer ServicesConsumer Services Functions as a College/University | Chairman | 31/05/2011 |
| ░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Jean-François Dehecq
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Veolia Environnement SA
Veolia Environnement SA Water UtilitiesUtilities Provides water supply, wastewater treatment, waste management and district heating services | Utilities |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Air France-KLM SA
Air France-KLM SA AirlinesTransportation Provides passenger and cargo air transportation services | Transportation |
Arts Et Metiers Paristech
Arts Et Metiers Paristech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pierre Balmain SAS
Pierre Balmain SAS Apparel/FootwearConsumer Non-Durables Designs and markets clothing collections for women and men | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Provepharm SAS
Provepharm SAS Pharmaceuticals: MajorHealth Technology Produces and supplies methylthioninium chloride products | Health Technology |
Bpifrance Participations SA /PRIVATE EQUITY/
Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance BPIfrance Participations PE is an active, medium-term manager which aims to support small,medium and intermediate-sized French companies with growth potential, particularly in technology-related sectors. They also invest in large companies with liquidity issues and may exceptionally consider investing directly in seed and start-up companies. The firm targets companies with strong products and significant long-term sales potential which are facing short-term balance sheet difficulties. Their key investment criteria include viability and profitability. They get actively involved in strategic decisions, encourage the R&D activity within their investee companies, and promote social and environmental responsibility. BPIfrance Participations PE invests primarily in the form of direct equity, possibly complemented with near equity, convertible debt and warrants. They typically take minority stakes and favor co-investing with public or private sector partners, including foreign investors. They consider investments across sectors within the real economy, such as technology, industrials and services. They avoid financials, real estate, retail and non-competitive activities. The firm's exit horizon and strategy are flexible and take into account the time requirements of the R&D process as well as the state of the economy. | Finance |
L'Agence Nationale de la Recherche
L'Agence Nationale de la Recherche General GovernmentGovernment Promotes and funds scientific research efforts, public and private. | Government |
Association Nationale de la Recherche et de la Technologie
Association Nationale de la Recherche et de la Technologie Miscellaneous Commercial ServicesCommercial Services A business association for research companies. | Commercial Services |
Fondation Française pour la Recherche sur l'Epilepsie | |
Sanofi Espoir Corporate Foundation | |
Conference Nationale de l'Industrie | |
Groupe Maori SAS |
- Stock Market
- Insiders
- Jean-François Dehecq
















